Vialase
Lasers & Laser Systems · Health Care
$80.6Mtotal raised · 4 rounds on record
$45.2Mlatest round · Series C · Mar 2024 · 2 yr ago
1backers · Arboretum Ventures
39team · US Form 5500 (plan participants) · Dec 2025 · -3% in a year
Overview
ViaLase is redefining glaucoma treatment with 200+ years of combined experience creating femtosecond laser technology. Discover the new ViaLuxe Laser System.
Funding and backers
Total raised
$80.6M
4 rounds on record
Latest round
$45.2M
Series C · Mar 2024 · 2 yr ago
Team
39
US Form 5500 (plan participants) · Dec 2025 · -3% in a year
Backers
1
Arboretum Ventures
The money's age
Long since its last round
31 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 30, 2024
Certified ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase Laser · vialase.com
Mar 25, 2024
Raised a round Series C $45.2M · SEC Form D
Jan 5, 2024
Took on debt financing $3.5M · SEC Form D
Nov 15, 2022
New executive ViaLase Strengthens Executive Team with the Appointments of Tom Frinzi as Executive Chairman of the Board, Richard Lewis, M.D., as Chief Medical Offi… · PRNewswire
Nov 15, 2021
Raised a round Venture round $27.3M · SEC Form D
Mar 20, 2019
Raised a round Venture round $8.1M · SEC Form D
2019
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series C | Mar 2024 | $45.2M | — | SEC Form D |
| Debt Financing | Jan 2024 | $3.5M | — | SEC Form D |
| Venture round | Nov 2021 | $27.3M | — | SEC Form D |
| Venture round | Mar 2019 | $8.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | ViaLase, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Tibor JuhaszExecutive Officer, DirectorSEC Form D
Scott CooperExecutive OfficerSEC Form D
Rick LewisExecutive OfficerSEC Form D
Hadi SrassExecutive OfficerSEC Form D
Shawn O'NeilExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Betaliq Inc.. Innovating glaucoma treatments.
Iris Lab develops counter-UAS laser systems, designed and built in Europe for mass-deployments.
TLC Laser Eye Centers is a leading laser eye surgery provider, celebrating 30 years of LASIK experience. Book a Free Consultation near you.
Momentum Optics manufactures high-performance, custom sphere, asphere, and freeform optics using a laser chemical process and high-quality…
活力激光 is a Chinese manufacturer of semiconductor lasers, pump sources, and high-power diode lasers for industrial, medical, and research use.
Discover inPhocal's laser technology for faster production, lower downtime, eco-friendly solutions, and unparalleled quality. Book a demo…
Visa sponsorship
1
H-1B filings in 12 months
$103k
Median offered salary
0
Open roles in United States
Who they sponsor
Software developers
1
In the register as ViaLase, Inc., Aliso Viejo, CA
Other sponsors in the same field
Kodiak Sciences 
SpyGlass Pharma™ 
Castle Biosciences 
Aerolase
Alert me
US Department of Labor · latest filing Jun 25, 2026 · Visa details by country
People
Tibor Juhasz
Executive Officer, Director
Scott Cooper
Executive Officer
Rick Lewis
Executive Officer
Hadi Srass
Executive Officer
Shawn O'Neil
Executive Officer
Tim Petersen
Director
William Link
Director
James Adox
Director
Jim Adox
Director
Tom Frinzi
Director
Franck Leveiller
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Arboretum VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care Aliso Viejo, Calif. - May
Read more
Report
ViaLase to Present Multiple Scientific Papers at the 2026 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Aliso Viejo, Calif. - April 29, 2026 - ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that it will present new scientific research during the 2026 Association for
Read more
Report
ViaLase to Present Multiple Scientific Papers at the 2026 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
ALISO VIEJO, Calif., April 29, 2026--At ARVO 2026, ViaLase will present research that explores multi-aperture treatment strategies with a femtosecond laser trabeculotomy procedure.
Read more
Report
ViaLase Announces First Patient Treated in IDE Clinical Trial Evaluating Its Femtosecond Laser Trabeculotomy for Open-Angle Glaucoma
Prospective, randomized controlled trial compares novel femtosecond laser procedure to selective laser trabeculoplasty (SLT), advancing path to US commercialization Aliso Viejo, Calif. - December 3, 2025 - ViaLase, Inc., a clinical-stage medical technolog
Read more
Report
ViaLase Announces First Patient Treated in IDE Clinical Trial Evaluating Its Femtosecond Laser Trabeculotomy for Open-Angle Glaucoma
Read more
Report
ViaLase to Present at the 42nd Congress of the European Society of Cataract and Refractive Surgeons
ViaLase, Inc. 42nd Congress of the European Society of Cataract and Refractive Surgeons Spain California
Read more
Report
ViaLase Announces Strategic Leadership Transitions to Support Commercial Growth
Aliso Viejo, Calif. - July 8, 2025 - ViaLase, Inc., a medical technology company pioneering noninvasive femtosecond laser treatments for glaucoma, today announced key changes to its executive leadership team as the company prepares for commercial launch a
Read more
Report
ViaLase, Inc.: ViaLase Announces Strategic Leadership Transitions to Support Commercial Growth
Read more
Report
ViaLase and the John A. Moran Eye Center Announce Research Partnership to Accelerate Glaucoma Research and Innovation
ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced...
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Aliso Viejo
United States
HQ
200-500 est. staff